fluorescein-5-isothiocyanate has been researched along with Staphylococcal Infections in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Fan, B; Guan, YS; Li, Q; Qiao, J; Xu, X; Yang, H | 1 |
Kingston, J; Lavu, PS; Mondal, B; N, B; Ramlal, S | 1 |
Aljuffali, IA; Fang, JY; Huang, CW; Lee, WR; Lin, YK; Shen, SC | 1 |
Gallo, RL; Jann, NJ; Kristian, SA; Landmann, R; Nizet, V; Peschel, A; Radek, KA; Schmaler, M | 1 |
Krönke, M; Krut, O; Sommer, H | 1 |
Hryniewicz, W; Rózalska, B; Rozalska, S; Sadowska, B; Walencka, E | 1 |
Phillips, JR; Regelmann, WE; Schlievert, PM; Tripp, TJ; Wangensteen, OD | 1 |
7 other study(ies) available for fluorescein-5-isothiocyanate and Staphylococcal Infections
Article | Year |
---|---|
A metal-organic framework-based fluorescence resonance energy transfer nanoprobe for highly selective detection of
Topics: Fluorescein; Fluorescein-5-isothiocyanate; Fluorescence Resonance Energy Transfer; Humans; Metal-Organic Frameworks; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
Capture and detection of Staphylococcus aureus with dual labeled aptamers to cell surface components.
Topics: Aptamers, Nucleotide; Base Sequence; Flow Cytometry; Fluorescein-5-isothiocyanate; High-Throughput Screening Assays; Humans; Limit of Detection; SELEX Aptamer Technique; Staining and Labeling; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Animals; Dextrans; Drug Delivery Systems; Fluorescein; Fluorescein-5-isothiocyanate; Imiquimod; Lasers, Solid-State; Mice, Inbred BALB C; Mice, Nude; Peptides; Pseudomonas aeruginosa; Pseudomonas Infections; Quantum Dots; Skin; Skin Absorption; Staphylococcal Infections; Staphylococcus aureus; Swine; Tretinoin | 2016 |
Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin.
Topics: Animals; Antimicrobial Cationic Peptides; Cathelicidins; Cell Survival; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Lipopolysaccharides; Lysosomes; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus | 2009 |
Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antibodies, Bacterial; Cell Survival; Cells, Cultured; Colony Count, Microbial; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Mice; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Subcellular Fractions | 2004 |
Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication.
Topics: Anti-Infective Agents, Local; Biofilms; Fluorescein-5-isothiocyanate; Formazans; Humans; Lysostaphin; Microbial Sensitivity Tests; Microscopy, Confocal; Oxacillin; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tetrazolium Salts | 2005 |
Staphylococcal alpha-toxin causes increased tracheal epithelial permeability.
Topics: Animals; Bacterial Toxins; Cell Membrane Permeability; Dextrans; Disease Models, Animal; Epithelium; Exotoxins; Fluorescein-5-isothiocyanate; Hemolysin Proteins; Male; Mice; Respiratory Mucosa; Staphylococcal Infections; Staphylococcus aureus; Trachea; Tracheitis | 2006 |